Exchange boss Helen Lofthouse said it is in the interests of the company and its shareholders for it to defend a case ...

ASX (ASX:ASX) filed its defence today in relation to proceedings initiated by the Australian Securities and Investments ...

Welcome to my ChartWatch Daily ASX Scans series. Here I present scan lists based on my trend following technical analysis ...

This caught the eye of analysts at Citi, which responded by placing a buy rating and $2.70 price target on the ASX dividend ...

We reveal the 10 best ASX 200 shares based on stock price gains since Donald Trump was elected the next President of the ...

The Australian sharemarket broke a three-day losing streak, with information technology and financials driving the market ...

In stock markets abroad, European indexes were higher, including a 1.4 per cent jump for Germany’s DAX. Asian markets were ...

In the pursuit of continued earnings growth, Aristocrat is at risk of overpaying for acquisitions in its competitively more ...

The S&P/ASX 200 closed 30.6 points higher, up 0.37%. Once again, pro-Trump Trade winners (i.e., those with direct US earnings ...

Recent election results have sent US markets into a record-high rally however implications remain mixed for the Australian ...

EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...

Australian shares were set to open higher. While European stocks advanced, there was a broad easing in New York. Bullish ...